Innoviz Technologies Ltd. Insider Trading Activity
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Innoviz Technologies Ltd. director Orit Stav reported a compensation-related equity grant. On May 13, 2026, Stav received 110,668 Restricted Share Units (RSUs), each representing a contingent right to one ordinary share, with no exercise price. These RSUs are scheduled to fully vest on April 5, 2027, if Stav remains a service provider through that date. Following this award, Stav directly holds 344,997 ordinary shares, which includes 234,329 already-issued ordinary shares.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Ordinary Shares | 110,668 | $0.00 | $0.00 |
Footnotes (2)
- F1. Represents 110,668 Restricted Share Units (RSUs) granted on May 13, 2026, which shall fully vest on April 5, 2027, subject to the Reporting Person remaining a service provider of the Issuer on the vesting date. Each RSU represents a contingent right to receive one ordinary share. No exercise price is applicable.
- F2. Includes 234,329 ordinary shares.
Key Figures
Key Terms
vest financial
contingent right financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Innoviz (INVZ) director Orit Stav report in this Form 4?
How many Innoviz (INVZ) RSUs were granted to Orit Stav and on what date?
When do the newly granted Innoviz (INVZ) RSUs for Orit Stav vest?
Does the Innoviz (INVZ) RSU grant to Orit Stav have an exercise price?
AI-generated analysis. How Rhea-AI works. Not financial advice.